AmerisourceBergen Corporation (NYSE: ABC) reported third quarter 2023 earnings results today.
Revenue increased 11.5% year-over-year to $66.9 billion.
Net income attributable to AmerisourceBergen Corporation rose 17.8% to $479.5 million while EPS increased 22.4% to $2.35.
Adjusted EPS increased 11.5% to $2.92.
US Healthcare Solutions revenue was $59.9 billion, up 12.2% YoY.
International Healthcare Solutions revenue was $7 billion, up 5.6% YoY.
FY2023 adjusted revenue is expected to grow at least 8%.
FY2023 adjusted EPS is expected to be $11.85-11.95.
In January, the company announced its intent to change its name. Effective August 30, 2023, the company will begin operating as Cencora and will begin trading on the New York Stock Exchange under the ticker symbol “COR”.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
